ICON Medical

ICON is a leading global provider of outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device, and government and public health organisations. The company specialises in the strategic development, management, and analysis of programs that support clinical development—from compound selection to Phase I-IV clinical studies. With the acquisition of PRA Health Sciences in 2021, ICON significantly expanded its scale and data capabilities, positioning itself as one of the largest contract research organisations (CROs) in the world. Its service offerings include clinical trial management, biometric services, medical imaging, and global consulting.